Tags

Type your tag names separated by a space and hit enter

Long-term Outcomes of MCP Surface Replacement Arthroplasty in Patients With Rheumatoid Arthritis.
Hand (N Y). 2020 Jun 02 [Online ahead of print]H

Abstract

Background:

Surface replacement arthroplasty (SRA) can be used in the treatment of rheumatoid arthritis (RA) affecting the metacarpophalangeal (MCP) joint. The authors of this study sought to investigate the outcomes of MCP SRA in patients with RA.

Methods:

Retrospective review of medical records and an institutional joint registry were used to gather data on 80 MCP SRAs performed in 27 patients with RA. Data collected included demographics, SRA revisions, reoperations, complications, pain, and MCP arc of motion.

Results:

The mean postoperative follow-up was 9.5 years (range, 2.1-20.5 years), with all SRAs achieving at least 2 years of follow-up. Thirteen digits (16%) underwent revision arthroplasty, and 29 (36%) required reoperation. The 5-, 10-, 15-, and 20-year rates of survival from implant revision were 95%, 85%, 80%, and 69%, respectively. The 5-, 10-, 15-, and 20-year rates of survival from overall reoperation were 80%, 65%, 55%, and 46%, respectively. Metacarpophalangeal joint arc of motion, grip strength, and pain levels significantly improved following surgery.

Conclusions:

Metacarpophalangeal SRA can offer benefit to patients with RA for improvement in function and pain. High overall reoperation rates remain concerning; however, most do not involve arthroplasty revision.

Authors+Show Affiliations

Mayo Clinic, Rochester, MN, USA.Emory University, Atlanta, GA, USA.Mayo Clinic, Rochester, MN, USA.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32486855

Citation

Claxton, Matthew R., et al. "Long-term Outcomes of MCP Surface Replacement Arthroplasty in Patients With Rheumatoid Arthritis." Hand (New York, N.Y.), 2020, p. 1558944720926631.
Claxton MR, Wagner ER, Rizzo M. Long-term Outcomes of MCP Surface Replacement Arthroplasty in Patients With Rheumatoid Arthritis. Hand (N Y). 2020.
Claxton, M. R., Wagner, E. R., & Rizzo, M. (2020). Long-term Outcomes of MCP Surface Replacement Arthroplasty in Patients With Rheumatoid Arthritis. Hand (New York, N.Y.), 1558944720926631. https://doi.org/10.1177/1558944720926631
Claxton MR, Wagner ER, Rizzo M. Long-term Outcomes of MCP Surface Replacement Arthroplasty in Patients With Rheumatoid Arthritis. Hand (N Y). 2020 Jun 2;1558944720926631. PubMed PMID: 32486855.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Long-term Outcomes of MCP Surface Replacement Arthroplasty in Patients With Rheumatoid Arthritis. AU - Claxton,Matthew R, AU - Wagner,Eric R, AU - Rizzo,Marco, Y1 - 2020/06/02/ PY - 2020/6/4/entrez KW - MCP joint KW - metacarpophalangeal joint arthritis KW - metacarpophalangeal joint arthroplasty KW - rheumatoid arthritis KW - surface replacement arthroplasty SP - 1558944720926631 EP - 1558944720926631 JF - Hand (New York, N.Y.) JO - Hand (N Y) N2 - Background: Surface replacement arthroplasty (SRA) can be used in the treatment of rheumatoid arthritis (RA) affecting the metacarpophalangeal (MCP) joint. The authors of this study sought to investigate the outcomes of MCP SRA in patients with RA. Methods: Retrospective review of medical records and an institutional joint registry were used to gather data on 80 MCP SRAs performed in 27 patients with RA. Data collected included demographics, SRA revisions, reoperations, complications, pain, and MCP arc of motion. Results: The mean postoperative follow-up was 9.5 years (range, 2.1-20.5 years), with all SRAs achieving at least 2 years of follow-up. Thirteen digits (16%) underwent revision arthroplasty, and 29 (36%) required reoperation. The 5-, 10-, 15-, and 20-year rates of survival from implant revision were 95%, 85%, 80%, and 69%, respectively. The 5-, 10-, 15-, and 20-year rates of survival from overall reoperation were 80%, 65%, 55%, and 46%, respectively. Metacarpophalangeal joint arc of motion, grip strength, and pain levels significantly improved following surgery. Conclusions: Metacarpophalangeal SRA can offer benefit to patients with RA for improvement in function and pain. High overall reoperation rates remain concerning; however, most do not involve arthroplasty revision. SN - 1558-9455 UR - https://www.unboundmedicine.com/medline/citation/32486855/Long-term_Outcomes_of_MCP_Surface_Replacement_Arthroplasty_in_Patients_With_Rheumatoid_Arthritis L2 - https://journals.sagepub.com/doi/10.1177/1558944720926631?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.